Druggable Target Discovery in Hypertensive Renal Injury: Vascular Purinergic Receptor X7

Menzies, Robert (Principal Investigator)

Status	Finished
Effective start/end date	1/01/16 → 31/07/19

Funding

UK-based charities: £287,850.00

Camk2n1 is a negative regulator of blood pressure, left ventricular mass, insulin sensitivity and promotes adiposity
Alfazema, N., Barrier, M., Marion de Procé, S., Menzies, R., Nicholas Carter, R., Stewart, K., Diaz, A. G., Moyon, B., Webster, Z., Bellamy, C. O. C., Arends, M. J., Stimson, R. H., Morton, N. M., Aitman, T. J. & Coan, P., Sept 2019, In: Hypertension. 74, 3, p. 687-696 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
The renal and blood pressure response to low sodium diet in P2X4 receptor knockout mice
Craigie, E., Menzies, R., Larsen, C. K., Jacquillet, G., Carrel, M., Wildman, S. S., Loffing, J., Leipziger, J., Shirley, D. G., Bailey, M. & Unwin, R. J., 22 Oct 2018, In: Physiological reports. 6, 20, e13899.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Purinergic Signaling in Kidney Disease
Menzies, R., Tam, F. W. K., Unwin, R. J. & Bailey, M., 22 Oct 2016, (E-pub ahead of print) In: Kidney International.
Research output: Contribution to journal › Literature review › peer-review

Open Access
File